Clinical Trial: A Study of Avutometinib for People With Solid Tumor Cancers
Study Status: Completed
Recruit Status: RECRUITING
Condition: Refractory Cancer
Study Type: INTERVENTIONAL
Official Title: A Multi-Center Phase I Dose Escalation Study of Avutometinib, a RAF/MEK Clamp, in Pediatric Patients With Refractory or Recurrent Solid Tumors Harboring Activating MAPK Pathway Alterations
Brief Summary:
The purpose of this study is to find out whether avutometinib is a safe treatment for advanced or recurrent solid tumor cancers in children and young adults.Researchers will look for the highest dose of avutometinib that is safe and cause few or mild side effects.
Read more